DE69621799D1 - Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen - Google Patents
Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungenInfo
- Publication number
- DE69621799D1 DE69621799D1 DE69621799T DE69621799T DE69621799D1 DE 69621799 D1 DE69621799 D1 DE 69621799D1 DE 69621799 T DE69621799 T DE 69621799T DE 69621799 T DE69621799 T DE 69621799T DE 69621799 D1 DE69621799 D1 DE 69621799D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- mania
- gabapentin
- derivatives
- bipolar disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 4
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 229960002870 gabapentin Drugs 0.000 title abstract 2
- 206010026749 Mania Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Beans For Foods Or Fodder (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/440,570 US5510381A (en) | 1995-05-15 | 1995-05-15 | Method of treatment of mania and bipolar disorder |
PCT/US1996/005898 WO1996036328A1 (en) | 1995-05-15 | 1996-04-26 | A method of treatment of mania and bipolar disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69621799D1 true DE69621799D1 (de) | 2002-07-18 |
DE69621799T2 DE69621799T2 (de) | 2003-01-02 |
Family
ID=23749281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69621799T Expired - Fee Related DE69621799T2 (de) | 1995-05-15 | 1996-04-26 | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen |
Country Status (19)
Country | Link |
---|---|
US (1) | US5510381A (de) |
EP (1) | EP0825857B1 (de) |
JP (1) | JPH11505244A (de) |
AT (1) | ATE218857T1 (de) |
AU (1) | AU702435B2 (de) |
CA (1) | CA2215923C (de) |
CZ (1) | CZ288072B6 (de) |
DE (1) | DE69621799T2 (de) |
DK (1) | DK0825857T3 (de) |
EE (1) | EE03420B1 (de) |
ES (1) | ES2177783T3 (de) |
GE (1) | GEP20002014B (de) |
HU (1) | HUP9802087A3 (de) |
NO (1) | NO315967B1 (de) |
NZ (1) | NZ307366A (de) |
PT (1) | PT825857E (de) |
SK (1) | SK281982B6 (de) |
WO (1) | WO1996036328A1 (de) |
ZA (1) | ZA963826B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
PL189872B1 (pl) | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu |
WO1999018063A2 (en) | 1997-10-07 | 1999-04-15 | Warner-Lambert Company | Process for preparing a cyclic amino acid anticonvulsant compound |
CU23048A3 (es) | 1997-10-27 | 2005-06-24 | Warner Lambert Co | Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos |
EP1077691B1 (de) * | 1998-05-15 | 2008-09-10 | Warner-Lambert Company LLC | Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung |
DK1077692T3 (da) | 1998-05-15 | 2004-12-06 | Warner Lambert Co | Aminosyrestabiliserede gabapentin- og pregabalinpræparater og fremgangsmåder til fremstilling deraf |
WO1999061424A1 (en) | 1998-05-26 | 1999-12-02 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
KR20010071778A (ko) * | 1998-07-09 | 2001-07-31 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 불면증의 치료를 위한 gaba 유사체의 용도 |
EP1121114B1 (de) * | 1998-10-16 | 2007-01-10 | Warner-Lambert Company Llc | Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen |
WO2000073300A1 (en) * | 1999-06-02 | 2000-12-07 | Warner-Lambert Company | Amino heterocycles useful as pharmaceutical agents |
AP2002002501A0 (en) * | 1999-10-07 | 2002-06-30 | Warner Lambert Co | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. |
HUP0301919A3 (en) * | 2000-06-16 | 2006-01-30 | Teva Pharma | Stable gabapentin having ph within a controlled range |
SK17922002A3 (sk) * | 2000-06-26 | 2003-11-04 | Warner-Lambert Company | Obdoby gabapentínu na liečenie porúch spánku |
ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
EP2575798B1 (de) | 2010-06-01 | 2017-08-09 | Rubicon Research Private Limited | Gastroretentive dosierungszubereitung von gaba analoga |
WO2015144825A1 (en) | 2014-03-27 | 2015-10-01 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral liquid pharmaceutical solution of gabapentin |
US11670410B1 (en) * | 2022-04-13 | 2023-06-06 | Green Sky Creations LLC | Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4355044A (en) * | 1980-12-19 | 1982-10-19 | Bernardo Heller | D-Phenylalanine treatment |
US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
-
1995
- 1995-05-15 US US08/440,570 patent/US5510381A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 GE GEAP19964027A patent/GEP20002014B/en unknown
- 1996-04-26 NZ NZ307366A patent/NZ307366A/en unknown
- 1996-04-26 DE DE69621799T patent/DE69621799T2/de not_active Expired - Fee Related
- 1996-04-26 EP EP96913852A patent/EP0825857B1/de not_active Expired - Lifetime
- 1996-04-26 CZ CZ19973558A patent/CZ288072B6/cs not_active IP Right Cessation
- 1996-04-26 ES ES96913852T patent/ES2177783T3/es not_active Expired - Lifetime
- 1996-04-26 CA CA002215923A patent/CA2215923C/en not_active Expired - Fee Related
- 1996-04-26 PT PT96913852T patent/PT825857E/pt unknown
- 1996-04-26 EE EE9700302A patent/EE03420B1/xx not_active IP Right Cessation
- 1996-04-26 AT AT96913852T patent/ATE218857T1/de not_active IP Right Cessation
- 1996-04-26 HU HU9802087A patent/HUP9802087A3/hu unknown
- 1996-04-26 SK SK1528-97A patent/SK281982B6/sk unknown
- 1996-04-26 AU AU56689/96A patent/AU702435B2/en not_active Ceased
- 1996-04-26 JP JP8534854A patent/JPH11505244A/ja not_active Ceased
- 1996-04-26 DK DK96913852T patent/DK0825857T3/da active
- 1996-04-26 WO PCT/US1996/005898 patent/WO1996036328A1/en active IP Right Grant
- 1996-05-14 ZA ZA963826A patent/ZA963826B/xx unknown
-
1997
- 1997-11-14 NO NO19975234A patent/NO315967B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0825857A1 (de) | 1998-03-04 |
EP0825857B1 (de) | 2002-06-12 |
ES2177783T3 (es) | 2002-12-16 |
PT825857E (pt) | 2002-11-29 |
NZ307366A (en) | 1999-10-28 |
NO315967B1 (no) | 2003-11-24 |
CZ355897A3 (cs) | 1998-02-18 |
CA2215923A1 (en) | 1996-11-21 |
ATE218857T1 (de) | 2002-06-15 |
WO1996036328A1 (en) | 1996-11-21 |
ZA963826B (en) | 1996-11-21 |
DE69621799T2 (de) | 2003-01-02 |
HUP9802087A2 (hu) | 1998-12-28 |
SK152897A3 (en) | 1999-05-07 |
EE9700302A (et) | 1998-06-15 |
GEP20002014B (en) | 2000-04-10 |
MX9707269A (es) | 1997-11-29 |
DK0825857T3 (da) | 2002-09-30 |
EE03420B1 (et) | 2001-06-15 |
CZ288072B6 (cs) | 2001-04-11 |
AU5668996A (en) | 1996-11-29 |
CA2215923C (en) | 2001-10-09 |
AU702435B2 (en) | 1999-02-18 |
JPH11505244A (ja) | 1999-05-18 |
NO975234D0 (no) | 1997-11-14 |
NO975234L (no) | 1997-11-14 |
SK281982B6 (sk) | 2001-09-11 |
HUP9802087A3 (en) | 1999-08-30 |
US5510381A (en) | 1996-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69621799D1 (de) | Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen | |
CY1106020T1 (el) | Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων | |
ATE142877T1 (de) | Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie | |
DE50015700D1 (de) | Substituierte indole zur modulierung von nfkb-aktivität | |
ATE203019T1 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane | |
DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
DE69201660D1 (de) | Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma. | |
TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência | |
ATE235915T1 (de) | Behandlung von hämorrhagischem virusfieber mit protein c | |
RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
DE69309790D1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-Furyl)-3-Derivate und pharmazeutische Präparate davon, zur Behandlung von Kardiovaskulär-Erkrankungen | |
DE69619051D1 (de) | Behandlung von Füllstoffen mit Oxasilacycloalkanen | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
DE59609977D1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
ES2144857T3 (es) | Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. | |
KR960003718A (ko) | 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 | |
DE69807586D1 (de) | Verwendung eines Alkylendioxybenzolderivats zur Behandlung von zirkadianen Schlafstörungen | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |